FDA unlikely to rule on Merck’s COVID pill before December

The Food and Drug Administration said Thursday it will ask its outside experts to meet in late November to scrutinize Merck’s pill to treat COVID-19.


You may also like

Brent crude oil

Brent crude oil

Crude oil

Crude oil